185 related articles for article (PubMed ID: 19060721)
1. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.
Phillips KA; Kelly MM
Int Clin Psychopharmacol; 2009 Jan; 24(1):26-8. PubMed ID: 19060721
[TBL] [Abstract][Full Text] [Related]
2. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
Phillips KA; Albertini RS; Rasmussen SA
Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials.
Beasley CM; Ball SG; Nilsson ME; Polzer J; Tauscher-Wisniewski S; Plewes J; Acharya N
J Clin Psychopharmacol; 2007 Dec; 27(6):682-6. PubMed ID: 18004137
[TBL] [Abstract][Full Text] [Related]
4. Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.
Tauscher-Wisniewski S; Disch D; Plewes J; Ball S; Beasley CM
Psychol Med; 2007 Nov; 37(11):1585-93. PubMed ID: 17640442
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine: no association with suicidality in obsessive-compulsive disorder.
Beasley CM; Potvin JH; Masica DN; Wheadon DE; Dornseif BE; Genduso LA
J Affect Disord; 1992 Jan; 24(1):1-10. PubMed ID: 1545040
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between fluoxetine and suicidality in bulimia nervosa.
Wheadon DE; Rampey AH; Thompson VL; Potvin JH; Masica DN; Beasley CM
J Clin Psychiatry; 1992 Jul; 53(7):235-41. PubMed ID: 1639742
[TBL] [Abstract][Full Text] [Related]
8. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.
Phillips KA
Am J Psychiatry; 2005 Feb; 162(2):377-9. PubMed ID: 15677604
[TBL] [Abstract][Full Text] [Related]
9. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
[TBL] [Abstract][Full Text] [Related]
10. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
[TBL] [Abstract][Full Text] [Related]
11. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
KoKoAung E; Cavenett S; McArthur A; Aromataris E
JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
[TBL] [Abstract][Full Text] [Related]
12. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
[TBL] [Abstract][Full Text] [Related]
14. Suicidality in pediatric patients treated with antidepressant drugs.
Hammad TA; Laughren T; Racoosin J
Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
[TBL] [Abstract][Full Text] [Related]
15. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study.
Phillips KA; Rasmussen SA
Psychosomatics; 2004; 45(5):438-44. PubMed ID: 15345790
[TBL] [Abstract][Full Text] [Related]
16. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ
Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973
[TBL] [Abstract][Full Text] [Related]
17. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder.
Lam RW; Levitt AJ; Levitan RD; Enns MW; Morehouse R; Michalak EE; Tam EM
Am J Psychiatry; 2006 May; 163(5):805-12. PubMed ID: 16648320
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial.
Han C; Pae CU; Lee BH; Ko YH; Masand PS; Patkar AA; Jung IK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):437-44. PubMed ID: 17950970
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine versus placebo in posttraumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
